SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041272
Filing Date
2023-08-10
Accepted
2023-08-10 16:01:27
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vor-20230630.htm   iXBRL 10-Q 2073334
2 EX-31.1 vor-ex31_1.htm EX-31.1 20809
3 EX-31.2 vor-ex31_2.htm EX-31.2 20813
4 EX-32.1 vor-ex32_1.htm EX-32.1 24090
  Complete submission text file 0000950170-23-041272.txt   7212936

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vor-20230630.xsd EX-101.SCH 41148
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vor-20230630_cal.xml EX-101.CAL 39854
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vor-20230630_lab.xml EX-101.LAB 338268
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vor-20230630_def.xml EX-101.DEF 124303
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vor-20230630_pre.xml EX-101.PRE 231791
52 EXTRACTED XBRL INSTANCE DOCUMENT vor-20230630_htm.xml XML 1445946
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 231159131
SIC: 2836 Biological Products, (No Diagnostic Substances)